BioSpace News Archive

Deals

Dassault Systèmes Completes Acquisition of Medidata Opening Up a New World of Virtual Twin Experiences for Healthcare

The 3DEXPERIENCE Platform combines modeling, simulation, data science, artificial intelligence and collaboration in the virtual world to achieve sustainable innovation in life sciences

October 29, 2019
·
5 min read
Pharm Country

Journal of Endovascular Therapy Publishes Peer Reviewed Article Highlighting Real-World Use of the Tack Endovascular System®

Study Demonstrates Safety and Efficacy of Intact Vascular’s Tack® Implants for Focal Dissection Repair in Complex Lesions

October 29, 2019
·
5 min read
BioCapital

CEL-SCI Corporation to Present at Dawson James Securities 5th Annual Small Cap Growth Conference

CEL-SCI Corporation, a Phase 3 cancer immunotherapy company, announced that Geert Kersten, Chief Executive Officer, will be presenting at the Dawson James Securities Small Cap Growth Conference on Tuesday, October 29th at 10:55 a.m. ET..

October 29, 2019
·
4 min read
Biotech Bay

BOYDSense diabetes device places among top innovations at 2019 RESI Innovation Challenge

Company’s non-invasive breath analysis technology recognized for its innovation and potential to disrupt glucose monitoring industry

October 29, 2019
·
3 min read
Business

Acceleron to Webcast Third Quarter 2019 Operating and Financial Results on November 6, 2019

Acceleron Pharma Inc. announced it will host a webcast and conference call on Wednesday, November 6, 2019 at 10:00 a.m. EST to discuss its third quarter 2019 operating and financial results..

October 29, 2019
·
1 min read
Policy

Endologix, Inc. Comments on Recent FDA Update on Type III Endoleaks with AFX® Endovascular AAA System

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced a response to the U.S. Food and Drug Administration update regarding Type III endoleaks with the AFX Endovascular AAA System..

October 29, 2019
·
8 min read
BioCapital

Incyte Reports 2019 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

Total product and royalty revenues of $534 million (+24% vs. Q3 2018) and Jakafi® (ruxolitinib) revenues of $433 million (+25% vs. Q3 2018) for the quarter ended September 30, 2019; raising full year 2019 Jakafi revenue guidance to a new range of $1.65-1.68 billion

October 29, 2019
·
24 min read
Genetown

New Plenity™ Pivotal Safety and Efficacy Data to be Presented at ObesityWeek 2019

Gelesis announced that the Company will deliver two oral presentations and one poster at ObesityWeek 2019, the annual combined congress of the American Society for Metabolic and Bariatric Surgery and The Obesity Society in Las Vegas, Nevada, from November 3-7, 2019.

October 29, 2019
·
5 min read
Deals

Acquisition in Canada’s Healthcare Sector - Logibec announces the acquisition of Knowlegde4You Corporation

Logibec Inc. announced the acquisition of Knowledge4You Corporation, a Markham, Ontario-based company.

October 29, 2019
·
2 min read
Business

Marinus Pharmaceuticals Appoints Joe Hulihan, M.D., as Chief Medical Officer

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy, depression and other neuropsychiatric disorders, today announced that Joe Hulihan, MD, has been appointed Chief Medical Officer

October 29, 2019
·
5 min read